Maree Therese Smith AC FAHMS is an Australian researcher, inventor and innovator based at the University of Queensland. She is executive director of the Centre for Integrated Preclinical Drug Development, and TetraQ (a drug testing facility), head of the Pain Research Group in the UQ School of Pharmacy, and the inventor and developer of a potential novel treatment for chronic pain, EMA401.[1][2]

Smith received a 2012 Life Sciences Queensland Industry Award for Excellence,[3] the 2015 Johnson & Johnson Innovation Industry Excellence Award for biotech industry leadership,[4] and the 2016 Australian Academy of Technological Sciences and Engineering Clunies Ross Award for contributions to the application of technology for the benefit of Australia.[5] She was elected a Fellow of the Australian Academy of Health and Medical Sciences in 2015.[6]

References

  1. ↑ "Professor Maree Smith FTSE - School of Pharmacy - The University of Queensland, Australia". Uq.edu.au. Archived from the original on 24 July 2016. Retrieved 20 June 2016.
  2. ↑ "University of Queensland Professor Maree Smith Awarded Prestigious Clunies Ross Award". The Daily Telegraph. Retrieved 20 June 2016.
  3. ↑ "Prof. Maree Smith receives Life Sciences award - School of Pharmacy - The University of Queensland, Australia". Uq.edu.au. 24 March 2014. Archived from the original on 13 June 2016. Retrieved 20 June 2016.
  4. ↑ "UQ pain drug inventor and $200m start-up win national awards - UQ News - The University of Queensland, Australia". Uq.edu.au. Retrieved 20 June 2016.
  5. ↑ "Prestigious award for UQ superstar scientist - UQ News - The University of Queensland, Australia". Uq.edu.au. Retrieved 20 June 2016.
  6. ↑ "Fellowship of the Australian Academy of Health and Medical Sciences" (PDF). Australian Academy of Health and Medical Sciences. October 2021. Retrieved 11 March 2022.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.